Skip to content

Prophylactic Antibiotic After Perineal Tear

Prophylactic Antibiotic Treatment for Perineal Tear After Delivery: a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04763486
Acronym
PATPET
Enrollment
2500
Registered
2021-02-21
Start date
2021-03-01
Completion date
2023-03-01
Last updated
2021-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Puerperal Infection

Brief summary

Current World Health Organization guidelines recommend routine antibiotic prophylaxis for women with perineal tear 3rd and 4th degree but not for 2nd degree because of insufficient evidence of effectiveness. The investigators aimed to investigate whether antibiotic prophylaxis prevented maternal infection after the first and second perineal tear after vaginal birth.

Detailed description

The PATPET trial is a randomized, controlled trial done at tertiary hospital obstetric units in Israel. Women who had first and second-degree tear (or after episiotomy) after delivery at 37 weeks or greater gestation, with no indication for ongoing prescription of antibiotics in the post-partum period and no contraindications to prophylactic Cefamezin (cefazolin), were randomly assigned (1:1) to receive a single intravenous dose of prophylactic antibiotic or not.

Interventions

DRUGCefazolin (Cefamezin)

Cefamezin 2 gr within 6 hour of delivery

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

parturition

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18-45 * perineal tear 2nd and 1st degree( episiotomy)

Exclusion criteria

* 3rd and 4 th degree perineal tear * antibiotic indication during delivery * cesarian section delivery

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with a fever after delivery6 weeks of deliveryMaternal fever above 38 C (Celsius)

Secondary

MeasureTime frameDescription
Way of delivery6 weeks of deliveryType of delivery- vacuum-assisted delivery vs. vaginally

Countries

Israel

Contacts

Primary ContactYair Daykan, Dr
yair.dykan@gmail.com+972542198231

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026